Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

NCT01740154 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Fatigue
Recurrent Renal Cell Cancer
Stage IV Renal Cell Cancer

Interventions

PROCEDURE: transcranial magnetic stimulation
PROCEDURE: electromyography
OTHER: survey administration
DRUG: sunitinib malate

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]